The Board of Directors of Aurobindo Pharma Limited at its meeting held on February 10, 2024, has accepted the resignation of Dr.(Mrs.) Avnit Bimal Singh (DIN: 01316166) as an Independent Director of the Company with effect from close of business hours on February 10, 2024. Consequently, she shall also cease to be the Chairperson of Stakeholders Relationship Committee, Member of the Nomination and Remuneration /Compensation Committee and Corporate Social Responsibilities Committee of the Company. Dr.(Mrs.) Avnit Bimal Singh further confirmed that there are no other material reasons other than those mentioned in her resignation letter.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,128 INR | +1.10% | -2.09% | +4.02% |
May. 08 | India's Hindalco mulls seeking $1.2 bln in Novelis IPO, Bloomberg News reports | RE |
May. 02 | Aurobindo Pharma Completes Sale of US Arm's Business Assets | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.02% | 7.91B | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
-2.71% | 159B |
- Stock Market
- Equities
- AUROPHARMA Stock
- News Aurobindo Pharma
- Aurobindo Pharma Limited Approves the Resignation of Dr.(Mrs.) Avnit Bimal Singh as an Independent Director